Ma Y, Zhang J, Yu N, Shi J, Zhang Y, Chen Z et al (2023) Effect of nanomaterials on gut microbiota
Translating all these advances mentioned above to clinical practice will require the construction of redox phenotyping panels with several biomarkers incorporating various sources of biomolecular and clinical data to guarantee a higher robustness and power of separation for a clinical test (Smith et al., 2021)
at the highest doses, gastrointestinal adverse events affected over 50% of participants, with most episodes mild to moderate
Simultaneous determination of loganin, morroniside, catalpol and acteoside in normal and chronic kidney disease rat plasma by UPLC-MS for investigating the pharmacokinetics of Rehmannia glutinosa and Cornus officinalis Sieb drug pair extract
Moreover a null mutant in GSH1 is embryo lethal 69